SLC38A10: A Potential Drug Target for Various Diseases (G124565)

Target Name: SLC38A10

NCBI ID: G124565

SLC38A10

SLC38A10: A Potential Drug Target for Various Diseases

SLC38A10, a member of the SLC (solute carrier protein) family 38, is a protein that plays a critical role in the transportation of various molecules across cell membranes. The SLC38A10 protein has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The SLC38A10 protein is a 38kDa protein that belongs to the SLC family 38. It is a transmembrane protein that is expressed in various tissues and cells in the body. The protein is involved in the transport of a wide range of molecules, including small molecules, ions, and proteins across cell membranes. It is a key component of the plasma membrane, which is the thin layer of lipid molecules that separates the cytoplasm from the cell nucleus.

SLC38A10 has been shown to be involved in various cellular processes, including cell signaling, neurotransmission, and insulin sensitivity. It has been shown to play a critical role in the regulation of ion channels, which are responsible for the flow of electrical impulses through the cell membrane. SLC38A10 has been shown to transport various ions across cell membranes, including Na+, K+, and Ca2+.

SLC38A10 has also been shown to be involved in the regulation of cell signaling pathways. It has been shown to play a critical role in the regulation of neurotransmitter release from nerve cells, which are responsible for transmitting signals throughout the body. interact with various neurotransmitter receptors, including dopamine, serotonin, and GABA.

In addition to its role in neurotransmission, SLC38A10 has also been shown to be involved in the regulation of insulin sensitivity. It has been shown to play a critical role in the regulation of cellular uptake of glucose, which is a key driver of hyperinsulinism, a condition in which the body produces too much insulin. SLC38A10 has been shown to interact with the insulin receptor, which is responsible for the regulation of glucose uptake and storage.

SLC38A10 has also been shown to be involved in the regulation of cell pathways related to metabolism. It has been shown to play a critical role in the regulation of lipid metabolism, including the transport of fatty acids across cell membranes. interact with various lipid molecules, including triglycerides and cholesterol.

SLC38A10 is a protein that has been shown to play a critical role in various cellular processes in the body. It has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Further research is needed to fully understand the role of SLC38A10 in these diseases and to develop effective treatments.

Protein Name: Solute Carrier Family 38 Member 10

Functions: Putative sodium-dependent amino acid/proton antiporter

The "SLC38A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC38A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets